Kathi Vidal confirmed as USPTO director; will focus on pro-bono

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Kathi Vidal confirmed as USPTO director; will focus on pro-bono

Kathi Vidal, the USPTO's new director

The Winston & Strawn managing partner and litigator was confirmed by the Senate in a voice vote after more than a year with no director

Kathi Vidal was confirmed as USPTO director by the Senate last night, April 5, in a voice vote.

Now she has been confirmed, Vidal will likely focus on broadening pro-bono programmes at the USPTO, according to office sources.

One source said Vidal highlighted her desire to make this subject one of her priorities during pre-confirmation meetings at the office.

Such a focus would be in-keeping with her record as a private practice lawyer. Vidal was very involved with Winston & Strawn’s pro-bono efforts.

Vidal, a patent litigator and managing partner at Winston & Strawn in California, will come into her new role after more than a year with no nominated USPTO director.

Former director Andrei Iancu stepped down from the role in January 2021. Drew Hirshfeld, the USPTO’s patent commissioner, has been performing the duties and functions of the director since then, essentially serving as an acting director.

Some intellectual property stakeholders were jubilant at the announcement. The Innovation Alliance’s executive director Brian Pomper said: “As a leading patent attorney and intellectual property expert, Ms Vidal brings the kind of experience we need at the USPTO.

“We also believe she has the leadership qualities required to be a successful, even-handed USPTO director.”

Several counsel told Managing IP last year that while Vidal’s nomination was still a rumour, they were desperate to get a new director after such a long time without one.

“Even if someone landed the role who you didn’t agree with, at least you’d know where the office was going and could plan appropriately,” said a head of IP policy at an R&D company.

Vidal was confirmed by the Senate’s Judiciary Committee, along with Leonard Stark for a judgeship at the Court of Appeals for the Federal Circuit, in January. Stark was confirmed by the full Senate earlier this year.

Before that, the committee grilled the patent litigator on matters related to Section 101, standard essential patents, the Fintiv rule at the Patent Trial and Appeal Board and drug pricing.

Vidal was nominated by President Joe Biden on October 26 2021, 10 months after the last director left the role.

In the past, she has spoken to Managing IP about Ruth Bader Ginsburg and the District Court for the Western District of Texas.

more from across site and SHARED ros bottom lb

More from across our site

The firm reveals how its litigation strategies informed the arguments that took Masimo’s judgment past $818 million
The firm was rebuilding its IP practice through a string of patent hires and a Texas expansion, but its dissolution has put the newly built talent back into the market
AI can exploit longstanding gaps in copyright protection at remarkable speed, but EU law still provides tools to fight back, says Simon Hembt at Bird & Bird
The firm has tapped a local patent trio to establish a foothold in the market and broaden its national presence
New Asia-Pacific IP head Jonathan Chu is eyeing opportunities arising from Chinese technology licensing, overseas enforcement and increasingly IP-heavy cross-border deals
Europe’s largest intellectual property convention and trade fair is back: IP Service World 2026 takes place in Munich from November 23–25 – the 16th edition, with 1,400-plus attendees from 55-plus nations, 100-plus speakers, and 100-plus exhibitors. Three days. Two focused areas. One IP marketplace.
Mehmet Gün and Uğur Aktekin discuss four decades of change in Türkiye’s legal market, the firm’s commitment to independence and the challenge of building an institution that can outlast its founders
Boehringer Ingelheim has instructed a team from Kirkland, while Teva is being represented by Pinsent Masons
The Delhi High Court’s latest directions offer an opportunity to move beyond remedies against bad-faith registrations and address how suspicious applications are identified in the first place, says Fatima Baig at Lexlinc
Camilla Hamrin describes how the acquisition by Acapo Onsagers will impact Bergenstråhle’s trademark practice – and reflects on changes she has seen over 30 years in IP
Gift this article